A genetic screen to identify latent transforming growth factor β activators

被引:6
作者
Annes, J
Vassallo, M
Munger, JS
Rifkin, DB [1 ]
机构
[1] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA
[2] NYU, Sch Med, Dept Med, New York, NY 10016 USA
关键词
TGF beta; latent TGF beta activators; GFP; cell screen;
D O I
10.1016/j.ab.2003.11.029
中图分类号
Q5 [生物化学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
dThe mechanisms by which latent transforming growth factor beta (TGFbeta) is converted to the active cytokine are largely unknown. Here we present a genetic screen that combines retroviral mutagenesis and cDNA expression cloning to reveal proteins involved in the extracellular regulation of latent TGFbeta activation. The screen employs a cell line engineered to express green fluorescent protein (GFP) in response to TGFbeta. The cells produce their own latent TGFbeta. Therefore, after transduction with a retroviral cDNA library that contains an insert for an activator of latent TGFbeta, cells expressing the activator are GFP-bright. These cells are enriched by fluorescence-activated cell sorting and grown as individual clones. The isolated clones are cocultured with a second TGFbeta reporter cell line that produces luciferase in response to TGFbeta. Cells that have acquired the ability to activate latent TGFbeta induce luciferase expression in the absence but not in the presence of neutralizing antibodies to TGFbeta. The activator expressed by the positive clones can be identified by retrieval of the retrovirus cDNA insert. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:45 / 54
页数:10
相关论文
共 42 条
[1]
AN ASSAY FOR TRANSFORMING GROWTH-FACTOR-BETA USING CELLS TRANSFECTED WITH A PLASMINOGEN-ACTIVATOR INHIBITOR-1 PROMOTER LUCIFERASE CONSTRUCT [J].
ABE, M ;
HARPEL, JG ;
METZ, CN ;
NUNES, I ;
LOSKUTOFF, DJ ;
RIFKIN, DB .
ANALYTICAL BIOCHEMISTRY, 1994, 216 (02) :276-284
[2]
Making sense of latent TGFβ activation [J].
Annes, JP ;
Munger, JS ;
Rifkin, DB .
JOURNAL OF CELL SCIENCE, 2003, 116 (02) :217-224
[3]
The integrin αVβ6 binds and activates latent TGFβ3 [J].
Annes, JP ;
Rifkin, DB ;
Munger, JS .
FEBS LETTERS, 2002, 511 (1-3) :65-68
[4]
ANZANO MA, 1982, CANCER RES, V42, P4776
[5]
Mechanisms of disease:: Role of transforming growth factor β in human disease. [J].
Blobe, GC ;
Schiemann, WP ;
Lodish, HF .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (18) :1350-1358
[6]
TRANSFORMING GROWTH-FACTOR-BETA IN DISEASE - THE DARK SIDE OF TISSUE-REPAIR [J].
BORDER, WA ;
RUOSLAHTI, E .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (01) :1-7
[7]
MEDIATION OF GLUCOCORTICOID RECEPTOR FUNCTION BY THE ACTIVATION OF LATENT TRANSFORMING GROWTH-FACTOR-BETA-1 IN MG-63 HUMAN OSTEOSARCOMA CELLS [J].
BOULANGER, J ;
REYESMORENO, C ;
KOUTSILIERIS, M .
INTERNATIONAL JOURNAL OF CANCER, 1995, 61 (05) :692-697
[8]
Thrombospondin-1 is a major activator of TGF-β1 in vivo [J].
Crawford, SE ;
Stellmach, V ;
Murphy-Ullrich, JE ;
Ribeiro, SMF ;
Lawler, J ;
Hynes, RO ;
Boivin, GP ;
Bouck, N .
CELL, 1998, 93 (07) :1159-1170
[9]
Expression and action of transforming growth factor beta (TGFβ1, TGFβ2, and TCFβ3) during embryonic rat testis development [J].
Cupp, AS ;
Kim, G ;
Skinner, MK .
BIOLOGY OF REPRODUCTION, 1999, 60 (06) :1304-1313
[10]
Expression cloning of new receptors used by simian and human immunodeficiency viruses [J].
Deng, HK ;
Unutmaz, D ;
KewalRamani, VN ;
Littman, DR .
NATURE, 1997, 388 (6639) :296-300